The use of human iPSC‐derived alveolar organoids to explore SARS‐CoV‐2 variant infections and host responses
Journal of Medical Virology · 2024
DOI: 10.1002/jmv.29579 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Chaitanya Gandikota und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiological Sciences, The Lundberg-Kienlen Lung Biology and Toxicology Laboratory, Oklahoma State University, Stillwater, Oklahoma, U…. Hauptthemen laut MEDLINE: COVID-19, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Severe acute respiratory syndrome‐related coronavirus 2 (SARS‐CoV‐2) primarily targets the respiratory system. Physiologically relevant human lung models are indispensable to investigate virus‐induced host response and disease pathogenesis. In this study, we generated human induced pluripotent stem cell (iPSC)‐derived alveolar organoids (AOs) using an established protocol that recapitulates the sequential steps of in vivo lung development. AOs express alveolar epithelial type II cell protein markers including pro‐surfactant protein C and ATP binding cassette subfamily A member 3. Compared to primary human alveolar type II cells, AOs expressed higher mRNA levels of SARS‐CoV‐2 entry factors, angiotensin‐converting enzyme 2 (ACE2), asialoglycoprotein receptor 1 (ASGR1) and basigin (CD147). Considering the localization of ACE2 on the apical side in AOs, we used three AO models, apical‐in, sheared and apical‐out for SARS‐CoV‐2 infection. All three models of AOs were robustly infected with the SARS‐CoV‐2 irrespective of ACE2 accessibility. Antibody blocking experiment revealed that ASGR1 was the main receptor for SARS‐CoV2 entry from the basolateral in apical‐in AOs. AOs supported the replication of SARS‐CoV‐2 variants WA1, Alpha, Beta, Delta, and Zeta and Omicron to a variable degree with WA1 being the highest and Omicron being the least. Transcriptomic profiling of infected AOs revealed the induction of inflammatory and interferon‐related pathways with NF‐κB signaling being the predominant host response. In summary, iPSC‐derived AOs can serve as excellent human lung models to investigate infection of SARS‐CoV‐2 variants and host responses from both apical and basolateral sides.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiological Sciences, The Lundberg-Kienlen Lung Biology and Toxicology Laboratory, Oklahoma State University, Stillwater, Oklahoma, USA.
- Oklahoma Center for Respiratory and Infectious Diseases, Oklahoma State University, Stillwater, Oklahoma, USA.
- Department of Physiological Sciences, Oklahoma State University, Stillwater, Oklahoma, USA.
- Department of Veterinary Pathobiology, Oklahoma State University, Stillwater, Oklahoma, USA.
- Pulmonary and Critical Care Division, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
ORCID-Profile: Chaitanya Gandikota, Kishore Vaddadi, Lin Liu
Förderung
- BLRD VA
- NIH HHS
- NHLBI NIH HHS
- NIGMS NIH HHS
- NIAID NIH HHS
Zitieren
APA
Gandikota, C., Vaddadi, K., Sivasami, P., Huang, C., Liang, Y., Pushparaj, S., Deng, X., Channappanava, R., Metcalf, J. P., & Liu, L. (2024). The use of human iPSC‐derived alveolar organoids to explore SARS‐CoV‐2 variant infections and host responses. Journal of Medical Virology. https://doi.org/10.1002/jmv.29579
Vancouver
Gandikota C, Vaddadi K, Sivasami P, Huang C, Liang Y, Pushparaj S, et al. The use of human iPSC‐derived alveolar organoids to explore SARS‐CoV‐2 variant infections and host responses. Journal of Medical Virology. 2024. doi:10.1002/jmv.29579
BibTeX
@article{Gandikota2024,
author = {Gandikota, Chaitanya and Vaddadi, Kishore and Sivasami, Pulavendran and Huang, Chaoqun and Liang, Yurong and Pushparaj, Samuel and Deng, Xufang and Channappanava, Rudragouda and Metcalf, Jordan P and Liu, Lin},
title = {The use of human iPSC‐derived alveolar organoids to explore SARS‐CoV‐2 variant infections and host responses},
journal = {Journal of Medical Virology},
year = {2024},
doi = {10.1002/jmv.29579}
}
EUVIMED